Day: June 20, 2023

Almost half of respondents reported significant challenges related to a lack of integration between zero-trust solutions deployed on-premises and in the cloud

SUNNYVALE, Calif., June 20, 2023 (GLOBE NEWSWIRE) —

John Maddison, EVP Products and CMO at Fortinet

“The Fortinet 2023 State of Zero Trust Report shows that although more organizations are implementing a zero-trust strategy, they still face challenges related to integration. To successfully implement zero trust, organizations need solutions that are designed to converge networking and security and have the ability to span multiple environments, such as Fortinet Universal ZTNA and Universal SASE.”

News Summary
Fortinet^® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced the findings from its global 2023 State of Zero Trust report. The results provide an overview of the current state of zero-trust security efforts and the progress IT teams have made following the pandemic-initiated need to secure remote workers. The report also delves into the continuing challenges many organizations face in securing a hybrid workforce.

Key findings from the State of Zero Trust Report include:

• Organizations of all sizes are working to implement zero-trust strategies. Since the last survey in 2021, companies have deployed more solutions as part of their zero-trust strategies. The number of respondents that report being in the process of implementation is 66%, up from 54% in 2021. Companies are working to enable zero trust everywhere to minimize the impacts of a breach.
• Organizations continue to face challenges in implementing their zero-trust strategies. Although companies are moving forward, they still face challenges. Nearly half of respondents (48%) indicated that a lack of integration between the zero-trust solutions deployed on-premises and in the cloud is the most significant issue they need to address. Other reported challenges relate to end-to-end policy enforcement, application latency, and a lack of reliable information to help select and design a zero-trust solution.
• Solutions must cover both on-premises and remote users with a consistent application access policy and success has been mixed. Many companies need to secure access to applications both on-premises and outside of the network, and nearly 40% of respondents report still hosting more than half of their applications on-premises. It’s notable that 75% also have encountered issues because of relying on cloud-only ZTNA.
• The consolidation of vendors and solution interoperability is crucial. Deploying solutions from multiple vendors has led to challenges such as the introduction of new security gaps and high operations costs. Larger companies in particular are looking to consolidate solutions to simplify operations and reduce overhead.
• SASE is a priority. The top priorities for SASE solutions vary, but “security effectiveness” is the most significant, with 58% placing it in their top three priorities. According to 89% of respondents, SASE integration with their on-premises solutions is also very or extremely important.

Despite claims that everything is moving to the cloud, most organizations still have a hybrid application and data strategy in place. ZTNA needs to work no matter where applications and users are located, and respondents indicated that the top areas that a hybrid ZTNA strategy must cover include web applications (81%), on-premises users (76%), remote users (72%), on-premises applications (64%), and SaaS applications (51%).

About the Zero Trust Report:
The Zero Trust Report is based on a global survey of IT decision-makers aimed at better understanding how far along organizations are in their zero-trust journey. The survey is intended to better understand the following:

• How well zero trust and ZTNA are understood
• The perceived benefits and challenges in implementing a zero-trust strategy
• Adoption of and the elements included in a zero-trust strategy

The survey was conducted from March 30-April 2, 2023 with 570 IT and security leaders from 31 different countries, representing nearly all industries, including the public sector.

Additional Resources

• Download the full report.
• Read the blog for key takeaways from Fortinet’s 2023 Zero Trust Report.
• Register for our webinar with Gartner about demystifying SASE: Americas or Europe.
• Learn how to better secure access for remote users to applications anywhere with Fortinet Zero Trust Network Access.
• Find out about our single-vendor SASE solution, which provides consistent security for users both on and off the network.
• Learn about Fortinet’s free cybersecurity training, which includes broad cyber awareness and product training. As part of the Fortinet Training Advancement Agenda (TAA), the Fortinet Training Institute also provides training and certification through the Network Security Expert (NSE) Certification, Academic Partner, and Education Outreach programs.
• Learn more about FortiGuard Labs threat intelligence and research and Outbreak Alerts, which provide timely steps to mitigate breaking cybersecurity attacks.
• Learn more about Fortinet’s FortiGuard Security Services portfolio.
• Read about how Fortinet customers are securing their organizations.
• Follow Fortinet on Twitter, LinkedIn, Facebook, and Instagram. Subscribe to Fortinet on our blog or YouTube.

About Fortinet
Fortinet (NASDAQ: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere you need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet’s solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog, and FortiGuard Labs.

FTNT-O

Copyright © 2023 Fortinet, Inc. All rights reserved. The symbols ® and denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiMail, FortiSandbox, FortiADC, FortiAI, FortiAIOps, FortiAntenna, FortiAP, FortiAPCam, FortiAuthenticator, FortiCache, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCASB, FortiCentral, FortiConnect, FortiController, FortiConverter, FortiCWP, FortiDB, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevSec, FortiEdge, FortiEDR, FortiExplorer, FortiExtender, FortiFirewall, FortiFone, FortiGSLB, FortiHypervisor, FortiInsight, FortiIsolator, FortiLAN, FortiLink, FortiMoM, FortiMonitor, FortiNAC, FortiNDR, FortiPenTest, FortiPhish, FortiPlanner, FortiPolicy, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiSDNConnector, FortiSIEM, FortiSMS, FortiSOAR, FortiSwitch, FortiTester, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM and FortiXDR.

Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.

Media Contact: Travis Anderson Fortinet, Inc. 408-235-7700 pr@fortinet.com

Investor Contact: Peter Salkowski Fortinet, Inc. 408-331-4595 psalkowski@fortinet.com

Analyst Contact: Brian Greenberg Fortinet, Inc. 408-235-7700 analystrelations@fortinet.com

 

GlobeNewswire Distribution ID 8860659

Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies

ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and its clients to use the CHOZN® GS^-/- cell line for production of therapeutic proteins and antibodies. Following the agreement, the CHOZN GS^-/- cell line has been integrated into Curia’s cell line development workflow and is immediately available to Curia customers.

CHOZN® platform is a Chinese Hamster Ovary (CHO) mammalian cell expression system that allows for faster, simpler selection and scale-up of high-producing clones for production of biologics and therapeutic recombinant proteins. It includes high-performing CHO cell lines, paired media and feeds, optimized expression vectors and robust protocols. The glutamine synthetase GS knockout (GS-/-) cell line of the CHOZN platform is specially designed to help streamline selection, identification and scale-up of high-producing clones ideal for GMP manufacturing of recombinant protein drugs.

“We continue to strengthen our biologics development offerings from discovery through clinical manufacturing,” said Christopher Conway, President R&D, Curia. “The CHOZN GS^-/- cell line platform adds a widely accepted and commercially viable cell line to our capabilities. Our integrated offering accelerates therapeutic protein and antibody production and offers seamless tech transfer for optimal flexibility.”

Curia’s protein and antibody development experts offer a track record of accelerating progress, with a timeline in as little as 12 months from cell line development to phase I drug substance, depending on the manufacturability of the candidates.

The addition of the CHOZN platform strengthens Curia’s offerings as a complement to its existing proprietary CHO cell line, providing customers with a highly versatile and broadly applicable solution.

About Curia
Curia is a leading contract research, development, and manufacturing organization providing products and services from R&D through commercial manufacturing to pharmaceutical and biopharmaceutical customers. Curia’s nearly 4,000 employees at 29 locations across the U.S., Europe, and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

Curia Contact Information:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8859845

Curia ลงนามข้อตกลงการอนุญาตกับ MilliporeSigma เพื่อสนับสนุนการผลิตโปรตีนและแอนติบอดี

อัลบานี นิวยอร์ก, June 20, 2023 (GLOBE NEWSWIRE) — Curia ซึ่งเป็นองค์กรชั้นนำด้านการวิจัย การพัฒนาและการผลิตตามสัญญา ได้ประกาศในวันนี้ว่า บริษัทได้ลงนามในข้อตกลงการอนุญาตให้ใช้สิทธิ์กับ MilliporeSigma ซึ่งเป็นธุรกิจวิทยาศาสตร์เพื่อชีวิตในอเมริกาเหนือของ Merck KGaA เมืองดาร์มสตัดท์ ประเทศเยอรมนี ซึ่งช่วยให้ Curia และลูกค้าสามารถใช้เซลล์ไลน์ CHOZN® GS^-/- สำหรับการผลิตโปรตีนเพื่อการบำบัดรักษาและแอนติบอดีได้ ด้วยข้อตกลงดังกล่าว เซลล์ไลน์ CHOZN GS^-/- จะได้รับการรวมเข้ากับเวิร์กโฟลว์การพัฒนาเซลล์ไลน์ของ Curia และพร้อมใช้งานทันทีสำหรับลูกค้าของ Curia

แพลตฟอร์ม CHOZN® เป็นระบบการแสดงออกของเซลล์สัตว์เลี้ยงลูกด้วยนมในรังไข่หนูแฮมสเตอร์ของจีน (CHO) ที่ช่วยให้สามารถเลือกได้เร็วขึ้น ง่ายขึ้น และเพิ่มจำนวนโคลนที่ให้ผลผลิตสูงสำหรับการผลิตสารชีวภาพและโปรตีนรีคอมบิแนนต์ในการบำบัดรักษา ซึ่งประกอบด้วยเซลล์ไลน์ CHO ที่มีประสิทธิภาพสูง สื่อและฟีดที่จับคู่ เวกเตอร์สำหรับใช้ในการแสดงออกของยีนที่ปรับให้เหมาะสม และโปรโตคอลที่มีประสิทธิภาพ เซลล์ไลน์กลูตามีนซินเธเทส GS น็อกเอาต์ (GS-/-) ของแพลตฟอร์ม CHOZN ได้รับการออกแบบมาเป็นพิเศษเพื่อช่วยให้การเลือก การระบุ และการเพิ่มขนาดของโคลนที่ให้ผลผลิตสูงนั้นเหมาะสมสำหรับการผลิตยาโปรตีนรีคอมบิแนนท์ตามหลักเกณฑ์วิธีการที่ดีในการผลิต (GMP)

“เรายังคงเพิ่มความแข็งแกร่งให้กับการให้บริการการพัฒนาผลิตภัณฑ์ชีวภาพของเราจากการค้นพบผ่านการผลิตเพื่อใช้ในการวิจัยทางคลินิก” Christopher Conway ประธานแผนกวิจัยและพัฒนาของ Curia กล่าว “แพลตฟอร์มเซลล์ไลน์ CHOZN GS^-/- ได้เพิ่มเซลล์ไลน์ที่ได้รับการยอมรับอย่างกว้างขวางและมีศักยภาพในเชิงพาณิชย์ให้กับความสามารถของเรา การให้บริการแบบบูรณาการของเราช่วยเร่งการผลิตโปรตีนและแอนติบอดีเพื่อการบำบัดรักษา และให้บริการการถ่ายทอดเทคโนโลยีที่ราบรื่นเพื่อความยืดหยุ่นสูงสุด”

ผู้เชี่ยวชาญด้านการพัฒนาโปรตีนและแอนติบอดีของ Curia ได้เสนอประวัติของการเร่งความคืบหน้า โดยมีระยะเวลาเพียง 12 เดือนนับจากการพัฒนาเซลล์ไลน์ไปจนถึงสารของตัวยาระยะที่ 1 ทั้งนี้ขึ้นอยู่กับความสามารถในการผลิตของผู้สมัคร

การมีแพลตฟอร์ม CHOZN เพิ่มเติมนั้นช่วยเพิ่มความแข็งแกร่งให้กับการเสนอการให้บริการของ Curia ในฐานะส่วนเสริมของเซลล์ไลน์ CHO ที่เป็นกรรมสิทธิ์ของบริษัทที่มีอยู่ ซึ่งช่วยให้ลูกค้าได้รับโซลูชันที่หลากหลายและนำไปใช้ได้อย่างกว้างขวาง

เกี่ยวกับ Curia

Curia เป็นองค์กรการทำวิจัย การพัฒนา และการผลิตตามสัญญาชั้นนำที่นำเสนอผลิตภัณฑ์และให้บริการตั้งแต่การวิจัยและพัฒนา (R&D) ผ่านการผลิตเชิงพาณิชย์ให้แก่ลูกค้ายาและเวชภัณฑ์ชีวภาพ พนักงานเกือบ 4,000 คนของ Curia ใน 29 สาขาทั่วสหรัฐอเมริกา ยุโรป และเอเชีย ช่วยให้ลูกค้าเปลี่ยนจากความสงสัยไปสู่การแก้ไขปัญหา เรียนรู้เพิ่มเติมได้ที่CuriaGlobal.com

ข้อมูลสำหรับติดต่อ Curia:
Viana Bhagan
+1 518 512 2111
corporatecommunications@CuriaGlobal.com

GlobeNewswire Distribution ID 8860042

LONDON, June 20, 2023 (GLOBE NEWSWIRE) — Well-respected digital asset investment firm, Finance Me Consultancy, has announced the unveiling of their cutting-edge trading platform. This breakthrough platform empowers users with access to a comprehensive selection of digital asset investment prospects, sophisticated trading instruments, and professional guidance designed to facilitate passive income creation and replace traditional sources of earnings. After making an initial deposit, clients can anticipate profit generation within the first day, all delivered in a secure, straightforward, and efficient manner, including ease of withdrawals.

The platform delivers real-time market intelligence, in-depth analytics, and a user-friendly design to foster informed decision-making for investments. Edward James, Finance Me Consultancy’s CEO, has hailed the introduction of their novel trading platform as a transformational moment in the digital asset trading sector, offering a safe, smooth trading experience, exclusive investment prospects, and robust investment management.

Fimec

Employing state-of-the-art technology, the platform by Finance Me Consultancy offers exposure to an array of digital assets such as cryptocurrencies, tokens, and other novel asset types. There’s no necessity for specialized software or hardware, making it readily accessible to all. Clients will automatically receive daily dividends or returns directly into their accounts, which are available for withdrawal post the initial 24 hours.

Edward underscored the firm’s dedication to offering the premier trading experience, empowering clients with the tools to make informed trading choices, optimize their returns, and maintain a competitive edge in the dynamic world of digital assets. The trading platform from Finance Me Consultancy is available globally. Interested individuals are invited to visit their website to learn more about the firm’s investment ethos and the advantages of digital asset trading. The Wales, UK-based firm operates with the highest level of ethics, focused on delivering exceptional returns for clients.

In addition, the platform provides an opportunity to diversify your portfolio which is monitored and managed for a nominal commission fee. This platform generates at least 4% daily returns on diverse investments with a minimum deposit of £500. Additionally, a rewarding referral program provides a 10% commission. By introducing a new investor to the platform, you will earn a commission equivalent to 10% of the deposited amount. This is an excellent opportunity to earn additional income and introduce your network to the benefits of our services.

www.fimec.io

info@fimec.io

+447888873868

South Wales Business Park, Cardiff, Wales, United Kingdom

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/166861c1-5d3c-477b-bdaa-eea191500c06
https://www.globenewswire.com/NewsRoom/AttachmentNg/eda7cf83-dce7-4fb1-ae49-d1ba365f8fd2

GlobeNewswire Distribution ID 1000826157